Applied DNA Sciences Continues Support of DLA Counterfeit Mitigation Program

Strategic Insights -

Applied DNA Sciences has entered into a new contract with the Defense Logistics Agency's (DLA) Land and Maritime's Product Test Center (PTC) in Columbus, Ohio, to provide forensic authentication of DNA-marked components. This contract marks the continuation of the Company's support of the DLA's counterfeit mitigation initiatives, which began in 2014. The new contract has a maximum value of $1.04 million over a five-year performance term and outlines the provision of supplies and services, including the creation of unique DNA marks in various inks, QC authentication testing, and training.

Key Takeaways:

  • Applied DNA Sciences has been supporting the DLA's counterfeit mitigation initiatives since 2014.
  • The new contract has a maximum value of $1.04 million over a five-year performance term.
  • The Company will provide supplies and services, including the creation of unique DNA marks in various inks, QC authentication testing, and training.
  • The forensic authentication of DNA-marked components will enable the DLA to maintain continuity of services at the PTC and ensure the authenticity of components.
  • Applied DNA Sciences' LinearDNA platform has utility in various end-markets, including Gov/Mil, textiles, pharmaceuticals, and nutraceuticals.
  • The Company has also established a COVID-19 diagnostic and testing offering that is in the early stages of commercialization.

Statistics:

  • Maximum value of the contract: $1.04 million
  • Duration of the contract: Up to 5 years
  • Year the DLA counterfeit mitigation initiatives began: 2014
  • Number of end-markets for Applied DNA Sciences' LinearDNA platform: 5
  • Percentage of the Company's revenue from Gov/Mil sector: N/A

Sources:

  • Applied DNA Sciences press release, dated May 5, 2021 via Businesswire
  • Annual Report on Form 10-K, filed December 17, 2020 with the SEC
  • Quarterly Report on Form 10-Q, filed February 11, 2021 with the SEC